CTKB logo

Cytek Biosciences Stock Price

Symbol: NasdaqGS:CTKBMarket Cap: US$461.0mCategory: Pharmaceuticals & Biotech

CTKB Share Price Performance

US$3.64
-2.19 (-37.56%)
36.7% undervalued intrinsic discount
US$5.75
Fair Value
US$3.64
-2.19 (-37.56%)
36.7% undervalued intrinsic discount
US$5.75
Fair Value
Price US$3.64
AnalystConsensusTarget US$5.75

CTKB Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value US$5.75 36.7% undervalued intrinsic discount

APAC Markets And Recurring Revenues Will Support Life Sciences

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative

Recent CTKB News & Updates

No updates

Cytek Biosciences, Inc. Key Details

US$197.1m

Revenue

US$88.8m

Cost of Revenue

US$108.3m

Gross Profit

US$119.5m

Other Expenses

-US$11.3m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 06, 2025
Earnings per share (EPS)
-0.089
Gross Margin
54.94%
Net Profit Margin
-5.71%
Debt/Equity Ratio
1.3%

Cytek Biosciences, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About CTKB

Founded
1992
Employees
663
CEO
Wenbin Jiang
WebsiteView website
cytekbio.com

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

U.S. Market Performance

  • 7 Days: -2.7%
  • 3 Months: 11.4%
  • 1 Year: 20.5%
  • Year to Date: 5.9%
In the last week, the market has fallen 2.7%, dragged down most by the Financials. In the last year, the market is actually up 18%. Earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading